Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples